Browsing by Author Pagani, Olivia

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)Citation
2016Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT TrialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Pinotti, Graziella; Price, Karen N; Regan, Meredith; Tondini, Carlo; Viale, Giuseppe; Walley, Barbara; School of Public Health: Public HealthAbsolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials, Journal of Clinical Oncology, vol.34, 19, 2016,pp 2221-2230
2014Adjuvant exemestane with ovarian suppression in premenopausal breast cancerCoates, Alan; Burstein, Harold J.; Colleoni, Marco; et al, Various; Fleming, G. F.; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Perez, E. A.; Regan, Meredith M.; Tondini, Carlo; Walley, B; School of Public Health: Public HealthAdjuvant exemestane with ovarian suppression in premenopausal breast cancer, New England Journal of Medicine, vol.371, 2, 2014,pp 107-118
2013Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, Aron (Prof); Maibach, Rudolph; Pagani, Olivia; Price, Karen; Rabaglio, Manuela; Regan, Meredith; Ruepp, Barbara; Walley, B; School of Public Health: Public HealthAdjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials, The Breast, vol.22, 6, 2013,pp 1094-1100
2017Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFTCoates, Alan; Abdi, Ehtesham; Colleoni, Marco; Fleming, G. F.; Francis, P A; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Parmar, Vani; Pinotti, Graziella; Regan, Meredith M.; Ruhstaller, Thomas; Salim, Muhammad; Spazzapan, Simon; Tondini, Carlo; Walley, B. A.; NH&MRC Clinical Trials CentreConcurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT, Annals of Oncology, vol.28, 9, 2017,pp 2225-2232
2012CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trialCoates, Alan; Biasi, Maria Olivia; Bouzyk, Mark; Dell’Orto, Patrizia; Ditzel, Henrik; et al, various; Kammler, Roswitha; Leyland-Jones, Brian; Lyng, Maria; Pagani, Olivia; Regan, Meredith M.; Tang, Weining; Thurlimann, Beat; School of Public Health: Public HealthCYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial, Journal of the National Cancer Institute, vol.104, 6, 2012,pp 441-451
2016Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trialCoates, Alan; Aristarco, Valentina; et al, Various; Gray, Kathryn P; Johansson, Harriet; Macis, Debora; Pagani, Olivia; Puccio, Antonella; Regan, Meredith; Roux, Susanne; Viale, Giuseppe; School of Public Health: Public HealthImpact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial, Breast Cancer Research, vol.18, 1, 2016,pp 1-12
2015Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trialsCoates, Alan; Dell’Orto, Patrizia; Doimi, Franco; et al, Various; Fleming, G. F.; Francis, P A; Kammler, Roswitha; Pagani, Olivia; Regan, Meredith; Russo, Leila; Szoke, Janos; Walley, B; School of Public Health: Public HealthPredictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials, Breast Cancer Research and Treatment, vol.154, 2, 2015,pp 275-286
2008Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?Coates, Alan; et al, Various; Fleming, G. F.; Francis, P A; Pagani, Olivia; Perez, E. A.; Price, K N; Regan, Meredith M.; Thurlimann, Beat; Torrisi, R; Walley, B; School of Public Health: Public HealthPremenopausal endocrine-responsive early breast cancer: who receives chemotherapy?, Annals of Oncology, vol.19, 7, 2008,pp 1231-1241
2012Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancerCoates, Alan; Aldridge, Julie; Bernhard, J; Cardoso, Fatima; Gelber, Richard D. (Prof); Goldhirsch, A; Harvey, V; Pagani, Olivia; Phillips, Kelly-Anne; Price, Karen N.; Ribi, Karin; Thompson, Alastair; Thurlimann, Beat; School of Public Health: Public HealthSubjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer, British Journal of Cancer, vol.106, 10, 2012,pp 1618-1625
2017Treatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trialsCoates, Alan; Bernhard, J; et al, Various; Francis, Prudence; Gomez, Henry; Luo, Weixiu; Pagani, Olivia; Regan, Meredith M.; Ribi, Karen; Saha, Poornima; Walley, Barbara; NH&MRC Clinical Trials CentreTreatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trials, Journal of Clinical Oncology, vol.35, 27, 2017,pp 3113-3122